VCAM-1 has also been reported to predict poor long-term outcome in other patient groups at risk of CVD, that is, in hemodialysis patients [35], in patients with diabetic nephropathy [36] and in patients with manifest CAD [37]. The gene discussed is VCAM1; the disease is diabetic kidney disease.